Stay updated on Mepolizumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mepolizumab in Chronic Urticaria Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page displays details for Mayo Clinic’s mepolizumab study for chronic spontaneous urticaria, including eligibility criteria, study design, outcome measures, dates, and a study protocol document.
    Difference
    42%
    Check dated 2026-11-07T11:29:29.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site revision changed from v3.7.2 to v3.8.0. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T11:02:21.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition notice about using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T12:07:52.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page’s footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:08:57.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.7.1 instead of v3.7.0. The study record page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T13:43:15.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message and a Home link in place of the trial details.
    Difference
    0.5%
    Check dated 2026-10-03T14:35:20.000Z thumbnail image

Stay in the know with updates to Mepolizumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.